Contents

18 Rubella

18.6 Contraindications and precautions

18.6.1 Contraindications

The general contraindications that apply to all immunisations are relevant to MMR (see sections 1.4 and 11.6.1).

Anaphylaxis to a previous dose of MMR, MMRV or any of the vaccine components (including neomycin and gelatin) is a contraindication to a further dose of MMR or MMRV.

MMR vaccine should not be given to women who are pregnant, and pregnancy should be avoided for four weeks after immunisation.9 However, inadvertent immunisation with a rubella-containing vaccine in early pregnancy is no longer considered an indication for termination of pregnancy. There have been no cases of teratogenic damage from vaccine virus despite intensive surveillance in the US, the UK and Germany.1

18.6.2 PrecautionsTop

Egg allergy, including anaphylaxis, is not a contraindication for MMR vaccine. See section 11.6.3 for more information, and section 11.6.2 for further precautions.